CTCX
Price:
$0.1973
Market Cap:
$652.85K
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Industry
Biotechnology
IPO Date
2021-09-23
Stock Exchange
NASDAQ
Ticker
CTCX
According to Carmell Therapeutics Corporation’s latest financial reports and current stock price. The company's current ROE is 141.35%. This represents a change of 288.88% compared to the average of 36.35% of the last 4 quarters.
The mean historical ROE of Carmell Therapeutics Corporation over the last ten years is 50.86%. The current 141.35% ROE has changed 177.90% with respect to the historical average. Over the past ten years (40 quarters), CTCX's ROE was at its highest in in the June 2024 quarter at 240.90%. The ROE was at its lowest in in the September 2023 quarter at -54.81%.
Average
50.86%
Median
22.93%
Minimum
-62.41%
Maximum
220.01%
Discovering the peaks and valleys of Carmell Therapeutics Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 9.34%
Maximum Annual ROE = 220.01%
Minimum Annual Increase = -452.54%
Minimum Annual ROE = -62.41%
| Year | ROE | Change |
|---|---|---|
| 2024 | 220.01% | -452.54% |
| 2023 | -62.41% | -360.56% |
| 2022 | 23.95% | 9.34% |
The current ROE of Carmell Therapeutics Corporation (CTCX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
60.52%
5-year avg
50.86%
10-year avg
50.86%
Carmell Therapeutics Corporation’s ROE is greater than Tricida, Inc. (-355.98%), greater than Entero Therapeutics, Inc. (-24.65%), greater than Tectonic Therapeutic, Inc. (-27.11%), greater than Fresh Tracks Therapeutics, Inc. (-66.50%), greater than Xenetic Biosciences, Inc. (-64.62%), greater than Neuphoria Therapeutics Inc. (-7.94%), greater than BiondVax Pharmaceuticals Ltd. (-4.92%), less than Kineta, Inc. (71.50%), greater than Nabriva Therapeutics plc (-201.91%), less than ModivCare Inc. (686.75%),
| Company | ROE | Market cap |
|---|---|---|
| -355.98% | $5.95M | |
| -24.65% | $11.53M | |
| -27.11% | $335.58M | |
| -66.50% | $5.59M | |
| -64.62% | $3.11M | |
| -7.94% | $7.07M | |
| -4.92% | $4.97M | |
| 71.50% | $7.05M | |
| -201.91% | $323.00 | |
| 686.75% | $6.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carmell Therapeutics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Carmell Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Carmell Therapeutics Corporation's ROE?
How is the ROE calculated for Carmell Therapeutics Corporation (CTCX)?
What is the highest ROE for Carmell Therapeutics Corporation (CTCX)?
What is the 3-year average ROE for Carmell Therapeutics Corporation (CTCX)?
What is the 5-year average ROE for Carmell Therapeutics Corporation (CTCX)?
How does the current ROE for Carmell Therapeutics Corporation (CTCX) compare to its historical average?